Future studies to identify the molecules that interact with the ubiquitinated G-CSFR and the E3 ligase that is recruited to the phosphorylated G-CSFR should provide additional insights into the mechanisms that downregulate G-CSFR signaling, which are disrupted in patients with SCN/AML. The gene discussed is CSF3R; the disease is acute myeloid leukemia.